| Literature DB >> 27135349 |
Francesca Sparvoli1, Eleonora Cominelli2.
Abstract
Most of the phosphorus in seeds is accumulated in the form of phytic acid (myo-inositol-1,2,3,4,5,6-hexakisphosphate, InsP₆). This molecule is a strong chelator of cations important for nutrition, such as iron, zinc, magnesium, and calcium. For this reason, InsP₆ is considered an antinutritional factor. In recent years, efforts to biofortify seeds through the generation of low phytic acid (lpa) mutants have been noteworthy. Moreover, genes involved in the biosynthesis and accumulation of this molecule have been isolated and characterized in different species. Beyond its role in phosphorus storage, phytic acid is a very important signaling molecule involved in different regulatory processes during plant development and responses to different stimuli. Consequently, many lpa mutants show different negative pleitotropic effects. The strength of these pleiotropic effects depends on the specific mutated gene, possible functional redundancy, the nature of the mutation, and the spatio-temporal expression of the gene. Breeding programs or transgenic approaches aimed at development of new lpa mutants must take into consideration these different aspects in order to maximize the utility of these mutants.Entities:
Keywords: gene regulation; inositol phosphates; mineral deficiency; phytate; signal transduction
Year: 2015 PMID: 27135349 PMCID: PMC4844270 DOI: 10.3390/plants4040728
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Schematic representation of phytic acid biosynthetic pathway (black) and myo-inositol derived pathways for ascorbic acid and raffinose-type oligosaccharides (grey). The substrate supply, lipid independent (red) and lipid dependent (dark grey) sub-pathways for myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6) synthesis are indicated. MIPS, myo-inositol-3-phosphate synthase; IMP, bifunctional enzyme: myo-inositol-phosphate monophosphatase and galactose-1-phosphate phosphatase; MIOX, myo-inositol monooxygenase; MIK, myo-inositol kinase; IPK2, inositol 1,4,5-tris-phosphate kinase; ITPK, inositol 1,3,4-triphosphate 5/6-kinase; IPK1, inositol 1,3,4,5,6 pentakisphosphate 2-kinase; PtdIS, phosphatidyl inositol phosphate synthase; PtdI4K, phosphatidyl inositol 4-kinase; PtdIP5K, phosphatidyl inositol 4-phospate 5-kinase; PtdIns,phosphatidyl inositol; PtdInsP1, phosphatidyl inositol monophosphate; PtdInsP2, phosphatidyl inositol biphosphate; PLC, phospholipase C; MRP, multidrug-resistance-associated protein ATP-binding cassette; HXK, hexokinase; VIH, diphosphoinositol pentakisphosphate kinase; KCS1, inositol hexakisphosphate kinase. Dotted grey line indicates a second route for InsP7 synthesis, existing in eukaryotes but not found in plants.
Classification of lpa mutations on the basis of the affected function in the pathway for phytic acid synthesis and accumulation.
| Class | Gene Function | Effects on the Pathway |
|---|---|---|
| Type 1 | MIPS | Decrease in phytic acid accompanied by a molar increase in free phosphate |
| MIK | ||
| IMP | ||
| Type 2 | 2PGK | Decrease in phytic acid accompanied by a low increase in free phosphate and increased content of lower inositol phosphates (InsPs) |
| IPK2 | ||
| ITPK | ||
| IPK1 | ||
| Type 3 | MRP | Decrease in phytic acid accompanied by a molar increase in free phosphate and/or decrease in phytic acid in specific seed tissues |
| Putative sulfate transporter (sultr3;3) |
Figure 2Scheme showing and summarizing the diverse roles of inositol metabolism and phytic acid pathway in compatible pathways (orange), signal transduction (green), membrane biogenesis and trafficking (red), gene regulation (light blue), and as cofactors of regulatory proteins (violet). Light blue boxed enzymes and metabolites have been found localized both in the nucleus and in the cytosol.